Clinical Trial Update: A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) [Phase 2]

View source ↗

Summary

Phase 2 study assessing a single dose of BRTX 100 for chronic lumbar disc disease, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Disc Disease

Drugs mentioned

• BRTX 100

Snippet

Sponsor: BioRestorative Therapies | Conditions: Lumbar Disc Disease | Phase 2 | Status: RECRUITING